Unknown PHASE1 INTERVENTIONAL 2-arm NCT04282928

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonian

A Singlecenter, Randomized, Open Lable, Intervention Controlled Clinical Study on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonia

Sponsor: Shanghai East Hospital

Conditions Severe Pneumonia

Interventions Human umbilical cord mesenchymal stem cells Routine treatment

Updated 5 times since 2020 Last updated: Feb 21, 2020 Started: Feb 29, 2020 Primary completion: Jan 31, 2021 Completion: Mar 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04282928, this PHASE1 trial focuses on Severe Pneumonia and remains ongoing. Sponsored by Shanghai East Hospital, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Not Yet Recruiting PHASE1
Mar 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE1

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai East Hospital

Data source: Shanghai East Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China